182 related articles for article (PubMed ID: 34160166)
1. Anti-P 200 pemphigoid - The most common floor binding subepidermal autoimmune bullous disease in a tertiary care center in south India.
Rai R; Anand JB; Shanmugasekar C; Arunprasath P; Chaitra V; Zillikens D; Schimdt E
Indian J Dermatol Venereol Leprol; 2021; 87(6):787-791. PubMed ID: 34160166
[TBL] [Abstract][Full Text] [Related]
2. Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin.
Goyal N; Rao R; Shenoi SD; Pai S; Kumar P; Bhogal BS; Schmidt E; Zillikens D
Indian J Dermatol Venereol Leprol; 2017; 83(5):550-555. PubMed ID: 28749386
[TBL] [Abstract][Full Text] [Related]
3. Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.
Meijer JM; Diercks GF; Schmidt E; Pas HH; Jonkman MF
JAMA Dermatol; 2016 Aug; 152(8):897-904. PubMed ID: 27167149
[TBL] [Abstract][Full Text] [Related]
4. [Anti-p200 pemphigoid].
Holtsche MM; Goletz S; Zillikens D
Hautarzt; 2019 Apr; 70(4):271-276. PubMed ID: 30868255
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing Epidermolysis Bullosa Acquisita From Bullous Pemphigoid Without Direct Immunofluorescence.
Gardner KM; Crawford RI
J Cutan Med Surg; 2018; 22(1):22-24. PubMed ID: 28719980
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of a Simple Immunohistochemical Staining Technique to Differentiate Anti-p200 Pemphigoid From Other Autoimmune Blistering Diseases: A Report of 2 Cases.
García-Díez I; Martínez-Escala ME; Ishii N; Hashimoto T; Mascaró Galy JM; Pujol RM; Herrero-González JE
Actas Dermosifiliogr; 2017; 108(1):e1-e5. PubMed ID: 27095685
[TBL] [Abstract][Full Text] [Related]
7. Bullous pemphigoid in India: Review of cases registered in an autoimmune bullous disease clinic.
De D; Kaushik A; Handa S; Mahajan R; Chatterjee D; Saikia B; Saikia UN; Radotra BD; Minz RW
Indian J Dermatol Venereol Leprol; 2023; 89(4):553-557. PubMed ID: 35962510
[TBL] [Abstract][Full Text] [Related]
8. Utility of the pattern-based approach using BIOCHIP-indirect immunofluorescence in the evaluation of subepidermal bullous disorders.
Venkataswamy C; Vinayagam N; Shanmugasundaram S; Rai R
J Cutan Pathol; 2023 Mar; 50(3):259-265. PubMed ID: 36444506
[TBL] [Abstract][Full Text] [Related]
9. Anti-p200 pemphigoid.
Goletz S; Hashimoto T; Zillikens D; Schmidt E
J Am Acad Dermatol; 2014 Jul; 71(1):185-91. PubMed ID: 24767733
[TBL] [Abstract][Full Text] [Related]
10. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations.
Lazarova Z; Yancey KB
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):398-403. PubMed ID: 8784276
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of indirect immunofluorescence on sodium chloride-split skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita.
Yang B; Wang C; Chen S; Chen X; Zhou G; Tian H; Yu M; Zhang D; Shi Z; Zhang F
Indian J Dermatol Venereol Leprol; 2011; 77(6):677-82. PubMed ID: 22016274
[TBL] [Abstract][Full Text] [Related]
12. [Anti-p200 pemphigoid: a spectacular response to dapsone].
Munsch C; Prey S; Joly P; Meyer N; Lamant L; Livideanu C; Viraben R; Paul C
Ann Dermatol Venereol; 2011 Nov; 138(11):739-42. PubMed ID: 22078034
[TBL] [Abstract][Full Text] [Related]
13. IgA anti-p200 pemphigoid.
Wozniak K; Hashimoto T; Fukuda S; Ohyama B; Ishii N; Koga H; Dainichi T; Kowalewski C
Arch Dermatol; 2011 Nov; 147(11):1306-10. PubMed ID: 22106117
[TBL] [Abstract][Full Text] [Related]
14. A Korean case of anti-p200 pemphigoid.
Cho SB; Kim SC
Yonsei Med J; 2003 Oct; 44(5):931-4. PubMed ID: 14584115
[TBL] [Abstract][Full Text] [Related]
15. Serration pattern analysis as a practical adjunct tool for categorization of subepidermal autoimmune blistering diseases.
Arora S; Shetty VM; Rao CR; Pai SB; Rao R
Indian J Dermatol Venereol Leprol; 2021; 87(6):778-786. PubMed ID: 34491679
[TBL] [Abstract][Full Text] [Related]
16. Direct immunofluorescence microscopy of 1 mol/L sodium chloride-treated patient skin.
Domloge-Hultsch N; Bisalbutra P; Gammon WR; Yancey KB
J Am Acad Dermatol; 1991 Jun; 24(6 Pt 1):946-51. PubMed ID: 1869682
[TBL] [Abstract][Full Text] [Related]
17. 'Suction split' as a routine method to differentiate epidermolysis bullosa acquisita from bullous pemphigoid.
Feliciani C; Di Muzio M; Mohammad Pour S; Allegretti T; Amerio P; Toto P; Coscione G; Proietto G; Amerio P
J Eur Acad Dermatol Venereol; 1998 May; 10(3):243-7. PubMed ID: 9643329
[TBL] [Abstract][Full Text] [Related]
18. Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid.
Groth S; Recke A; Vafia K; Ludwig RJ; Hashimoto T; Zillikens D; Schmidt E
Br J Dermatol; 2011 Jan; 164(1):76-82. PubMed ID: 20854435
[TBL] [Abstract][Full Text] [Related]
19. Anti-p200 pemphigoid: a novel autoimmune subepidermal blistering disease.
Dilling A; Rose C; Hashimoto T; Zillikens D; Shimanovich I
J Dermatol; 2007 Jan; 34(1):1-8. PubMed ID: 17204094
[TBL] [Abstract][Full Text] [Related]
20. Rat bladder epithelium: a sensitive substrate for indirect immunofluorescence of bullous pemphigoid.
Delmonte S; Cozzani E; Drosera M; Parodi A; Rebora A
Acta Derm Venereol; 2000 May; 80(3):175-8. PubMed ID: 10954206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
